Should we be worried about Covid this winter?
Experts are not too concerned about a new variant of Covid but say monitoring should continue.
Similar Posts
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer by half after roughly three years,…
Child seizures caught on video may be a clue to solving unexplained crib deaths
The last bedtime of 17-month-old Hayden Fell’s life was heartbreakingly normal. Crib video shows the toddler in pajamas playing happily as his parents and sister sang “Wheels on the Bus” with his twin brother. The next morning, Hayden’s dad couldn’t wake him. The tot had become one of several hundred seemingly healthy U.S. toddlers and…
Edwards Lifesciences cooperating with EU antitrust regulators | Reuters News Agency
Health 27 September 2023, 2:03 pm 1 minute Reuters exclusively reported that US medical device maker Edwards Lifesciences, a global leader in its field, was the target of an EU antitrust raid a week ago on concerns that it may have abuse its market power. Shares in Edwards Lifesciences shed 2.5% in pre-market trade on…
What It Means For Reproductive Health If The FDA Is Forced To Pull Abortion Drug Mifepristone
A drug approved by the FDA over two decades ago for use in medical abortions and miscarriages is at risk of being pulled from the market after a decision by a Trump-appointed federal judge in Texas on Friday. However, a second federal judge in Washington state issued a competing ruling that would prohibit the FDA…
Contrite, shorn of theatrics – Johnson’s first day at inquiry
Boris Johnson mixed contrition with an effort to take on former colleagues who questioned him.
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
